Stocktoria
CapForce Inc. CFOR
CapForce Inc. (CFOR) earns a Piotroski F-score of 2/9 (weak financial health), with an Altman Z″ in the distress zone. It does not currently pay a dividend. FY2025 revenue was $30.2M at a 78.2% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
How it ranks in Services · percentile among 982 companies
Percentile vs other Services companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 2/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · distress zone
| Component | Value |
|---|---|
| Working capital / assets | -0.094 |
| Retained earnings / assets | -7.092 |
| EBIT / assets | 0.631 |
| Equity / liabilities | 5.139 |
Sector peers · similar-size Services companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| CFOR | CapForce Inc. | 2/9 | -14.09 | 1 | — |
| BGLC | BioNexus Gene Lab Corp | 4/9 | 13.26 | — | — |
| YDES | YD Bio Ltd | 1/9 | -1.35 | — | — |
| SERA | SERA PROGNOSTICS, INC. | 2/9 | -8.32 | — | — |
| ACON | Aclarion, Inc. | 4/9 | 4.23 | — | — |
| XGN | EXAGEN INC. | 3/9 | -14.91 | — | +19.7% |
| PSNL | Personalis, Inc. | 3/9 | 0.31 | — | -17.7% |
About CapForce Inc.
CapForce Inc., a precision medicine company, develops and commercializes molecular microbiology solutions for life threatening infectious diseases in the United States and internationally. The company offers Unyvero application cartridges, Unyvero systems, Acuitas AMR Gene Panel test products, and SARS CoV-2 test kits. It also provides laboratory services; and collaboration services, including funded software arrangements. In addition, the company offers listing sponsorship and consultancy services. CapForce Inc. was formerly known as OpGen, Inc. and changed its name to CapForce Inc. in February 2026. CapForce Inc. was incorporated in 2001 and is headquartered in Clarksburg, Maryland.
FAQ
Is CFOR financially healthy?
CapForce Inc.'s Piotroski F-score is 2/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the distress zone.
Does CFOR pay a dividend?
No, CapForce Inc. does not currently pay a dividend.
How profitable is CFOR?
In FY2025, CapForce Inc. had a net margin of 78.2% and a return on equity of 74.1%.
What is CFOR's P/E ratio?
CapForce Inc.'s trailing price-to-earnings (P/E) ratio is about 1.0×, based on its latest annual earnings.
Is CFOR a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on CapForce Inc.: a Piotroski F-score of 2/9, an Altman Z″ in the distress zone, a P/E of about 1.0×. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.